CLSN Archives - Page 3 of 9 - Blue Horseshoe Stocks

Blue Horseshoe Stocks: CNXS Recap & More

Connexus Corp. CNXS

After initially tagging CNXS on Thursday May 25th amid a major spike of bitcoin hysteria, we witnessed a low of .0007 in the stock, and in the six sessions that have followed it has been building up quite a head of steam.

From that initial observed low, CNXS has gone on to hit a high of .003. which represents a very nice move of 329% while volume over this recent period has been heightened considerably.

We’ve been noticing a few other newsletters finally catching on, but to our knowledge we were the first to the party on CNXS. We’ll continue to monitor its progress moving forward, and will remain interested provided it holds support at or above a previous area of resistance at .0018 on any pullbacks.

FitBit, Inc. FIT – Options Idea

After sitting on the sidelines for many months on FIT, and watching the stock get crushed, we’ve seen it beginning to come up off of its recently established 52-week lows and are beginning to see it as a potential value play.

If our inkling is correct, a play of FIT stock itself would likely work out rather well over the longer term, but as our readers are aware, we like to try to score big with options plays when an opportunity presents itself.

In this case, we’d like to signal a range of extended-term contracts with an August expiration, namely, the FIT 08/18 $5-7 Calls. This will give us plenty of time for FIT to restablish itself and hopefully mount the recovery that appears possible given the current look of the chart.

Celsion Corp. CLSN

Speaking of bottom plays, we’re noticing that CLSN has recently registered a new annual low on Wednesday, and has been attempting to gain some traction and come up off of that bottom.

With the stock very close to extreme oversold territory, we’ll want to place it on watch as a possible rebound play.

Extended Watchlist:
DVAX, HMNY, PERI, RFP, EXTR, FOR

Blue Horseshoe Stocks: Huge VRX Calls, New Ideas & More

Valeant Pharmaceuticals, Inc. VRX

Our latest round of VRX Calls will almost certainly go down as one of our best three-day swings on any idea we’ve ever formulated. Beginning on Tuesday when we offered up the VRX Weekly $10.50-12 Calls as a target range. That day the stock traded as low as 10.57 before beginning this epic run that facilitated some truly impressive gains. VRX continued to bull its way to new highs yesterday, hitting 14.55, which in itself represents a 38% rise over Tuesday’s low.

Just like we did in yesterday’s premarket report, we’ve included the intraday moves, as well as our overall observed gains.

$10.50 Calls – Daily Range: 1.95-3.89 – Daily Gain: 118% – Total Range: .40-3.89 – 3-Day Swing: 873%
$11 Calls – Daily Range: 1.46-3.50 – Daily Gain: 140% – Total Range: .18-3.50 – 3-Day Swing: 1844%
$11.50 Calls – Daily Range: 1.27-2.99 – Daily Gain: 135% – Total Range: .08-2.99 – 3-Day Swing: 3638%
$12 Calls – Daily Range: .51-2.51 – Daily Gain: 392% – Total Range: .02-2.51 – 3-Day Swing: 12450%

A hearty congratulations goes out to anyone who took advantage of one of our best ideas of the year so far!

Northern Dynasty Minerals Ltd. NAK

Following our alerts on the stock in March at which time we stated that we believed there was “serious upside potential” for NAK, the stock has proven our assumption to be accurate. It has lived up to that potential as well in recent week, and this morning we’re seeing the stock gapping up to new highs in the premarket today with shares changing hands for as much as 2.60.

From the 1.06 low we observed in March, that represents a roughly two-month upswing of 145%

Today’s heightened activity likely stems from the new announcement the company made via PR this morning. Its wholly-owned subsidiary, Alaska-based Pebble Limited Partnership, and the US Environmental Protection Agency have reached a settlement agreement with respect to the parties’ longstanding legal dispute.

Under the terms of the settlement agreement, EPA has agreed the Pebble Project can proceed into normal course permitting under the Clean Water Act and National Environmental Policy Act. (>View Full PR)

Snap, Inc. SNAP – Options Ideas

SNAP took a pounding yesterday after releasing earnings that many are referring to as a disaster, but is recovering in the premarket today. We want to try to signal a range of calls to coincide with what could be a significant course-correct.

We’re looking at the SNAP Weekly $18 Calls* for quick daytrading opportunities, as well as the SNAP 6/16 $18-19 Calls for a longer-term recovery idea.

Bonus Idea: AZN $32-33.50 Weekly Calls*

*Never attempt to trade weekly options on a Friday unless you are a highly experienced trader- it’s an exceedingly risky proposition.

Extended Watchlist:
ANY, TCCO, FNJN, CLSN, URRE, PBR,

Blue Horseshoe Stocks: ADPT Review & More

Adeptus Health, Inc. ADPT

We tagged ADPT in yesterday morning’s report after noticing some abnormal price action and volume in Tuesday post-market trading and in the premarket. It’s the first time we’ve ever mentioned the stock in our long history, and it set the bar high with an excellent rip right out of the starting gate.

The stock shot up like a rocket from a low of 1.12 to a high 3.70, which works out to a 230% pop. Following that huge morning run the stock pulled back and is searching for support, but with the kind of volume and activity we witnessed yesterday, we won’t write this one off entirely. The potential for another bounce is definitely there.

Bravatek Solutions, Inc. BVTK – We were just mentioning yesterday morning how a participant in our chatroom raised a flag on BVTK Tuesday before it went on a huge run of more than 500% on enormous volume. That momentum carried over really nicely into yesterday’s session, as the stock traded in a range from .0009 early on, all the way to a new high of .0035.

That 288% intraday pop coupled with the previous days enormous increase reinforces what we’ve been talking about in terms of certain plays in the subpenny arena being on fire right now.

To further enhance our point, the big gainers didn’t stop there for the daily trader’s chat. We picked up on a key PR put out by Innovativ Media Group, Inc. INMG tying them to cannabis shortly following the opening bell yesterday, and that put up an impressive performance for the day as well, running 195% from .0019 to .0056.

This call was made well after our premarket reports hit the wires, which demonstrates why we encourage all of our readers to also join in on our daily in-session live chats. Once again- to participate, simply create/sign into your Skype account and send a contact request to ‘stocksumo’.

Celsion Corp. CLSN

We also want to flag CLSN, which put out an interesting PR this morning pertaining to preclinical studies on its bladder cancer treatment under development. (>>View PR)

Meanwhile, the stock itself has been stair-stepping up off of its bottom since February, and must return to the 1.00-level or face delistment from the NASDAQ. We’ll be interested to keep an eye on this play in the weeks and months ahead.

Extended Watchlist:
EARS, RTTR, STAF, AVGR, TVIA

Blue Horseshoe Stocks: WFM Followup, ZSAN & More

Whole Foods Market, Inc. WFM – Options Update

Our primary focus for yesterday morning’s premarket report was our running options idea from last week. We were mentioning that the WFM 02/17 $30 and 30.50 Calls had begun to heat up, and we didn’t want to miss out on the activity that seemed ready to kick our idea into effect.

Our assumptions turned out to be accurate, with WFM stringing on another good session performance. The $30 Calls traded up from a low of .54 to .90 (+66%), while the $30.50’s made their way from .20-.42 (+110%).

We also mentioned that a break of the 50DMA at 30.76 for WFM would prompt us to look at contracts with a higher strike price and later expiration, the WFM 02/24 $31 Calls. We did indeed witness a breach of that price point toward the end of the session, and those calls came into play as well, running from 20-.35 for a chance at a nice 75% gain.

Should the solid uptrend WFM has been putting together continue into future sessions, these could be an ongoing item of interest for us.

Zosano Pharma Corp. ZSAN

ZSAN is a play we highlighted on Monday after the company reported that in its ZOTRIP pivotal efficacy study, its M207 transdermal migraine therapy patch met both primary, as well as secondary endpoints.

We mentioned that not only were we going to experience the effect of positive study data, but a technically ripening chart as well, leading us to put the stock on high alert in coming sessions.

It was a good decision, as the stock has really gained momentum this week, putting together some solid sessions. In fact, yesterday the stock closed as the NASDAQ’s top gainer of the day. We’ve watched as ZSAN has traded up from a low of 1.65 to yesterday’s new high of 3.49, representing an intraweek upswing of 112% Cheers to those of our readers who came along for the ride!

Opko Health, Inc. OPK

We put OPK on bottom watch earlier this month, and after a few sessions of further consolidation, the past four trading days have shown some convincing bottom-bounce action.

The stock ultimately found support at the 7.99-level last week, from which it has logged five straight sessions of higher highs and higher lows, reaching 8.66 yesterday. While that action only equates to an 8% increase, it’s the massive gap on the chart to the upside from just under $10 to just over $11.50. We’ll look for the stock to continue to build gradually and maintain the current trend in hopes of seeing a run toward a gap-fill.

FRESH OPTIONS IDEA:

Kate Spade & Co. KATE Weekly $20 and $21 Calls

Extended Watchlist:
RSII, MAXD, SRMX, CLSN, TPX

Blue Horseshoe Stocks: MCIG Review & More

mCig, Inc. MCIG

The first thing we want to do to kick off the short trading week, is rehash the recent performance of MCIG. In our first report of the year, we were reminding our members of our ongoing interest in the cannabis sector and related fields, and gave a laundry list of plays that we wanted to track going forward from that point.

The following morning, we would observe a low of .1599 in MCIG, before it began a two week bullish run, and it hasn’t looked back since.

On Friday, MCIG attained a new three-year high of .38, where it also closed. That works out to an overall increase of 138% that we’ve witnessed with MCIG in the first two weeks of 2017. With the strong close, we’ll be sure to watch its activity closely as we head into the third.

Retractable Technologies, Inc. RVP

The next thing crossing our screens that we feel warrants some attention is the present situation with RVP. We took notice of a Form-4 filing last week, alluding to the purchase of a large block of shares by the CEO. Thomas Shaw picked up two million shares at .89, just a penny above the stock’s four-year low of .88, which was recorded on Friday.

With listing standards stipulating the maintenance of a PPS of at least a dollar, and the added confidence engendered by an executive placing faith in his stock through purchase on the open market, we feel RVP has the makings of a prime bottom-play, and we’ll be very interested to track its progress in this regard.

Extended Watchlist:
HWAL, GNBT, VDRM, PSNX, CLSN